Quadrant Capital Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$643K Sell
5,658
-268
-5% -$30.5K 0.02% 721
2025
Q1
$623K Buy
5,926
+5,889
+15,916% +$619K 0.02% 600
2024
Q4
$3.97K Hold
37
﹤0.01% 2361
2024
Q3
$3.7K Hold
37
﹤0.01% 2379
2024
Q2
$3.12K Hold
37
﹤0.01% 2404
2024
Q1
$2.71K Hold
37
﹤0.01% 2451
2023
Q4
$2.64K Sell
37
-110
-75% -$7.86K ﹤0.01% 2417
2023
Q3
$8.81K Sell
147
-107
-42% -$6.41K ﹤0.01% 2023
2023
Q2
$18.3K Buy
254
+7
+3% +$505 ﹤0.01% 1754
2023
Q1
$18.2K Buy
247
+107
+76% +$7.87K ﹤0.01% 1746
2022
Q4
$9.35K Sell
140
-105
-43% -$7.01K ﹤0.01% 1979
2022
Q3
$13K Buy
245
+219
+842% +$11.6K ﹤0.01% 1768
2022
Q2
$1K Buy
26
+7
+37% +$269 ﹤0.01% 2392
2022
Q1
$1K Hold
19
﹤0.01% 2331
2021
Q4
$2K Sell
19
-10
-34% -$1.05K ﹤0.01% 2151
2021
Q3
$3K Buy
29
+10
+53% +$1.03K ﹤0.01% 2034
2021
Q2
$2K Hold
19
﹤0.01% 2112
2021
Q1
$2K Hold
19
﹤0.01% 2082
2020
Q4
$1K Buy
+19
New +$1K ﹤0.01% 2139
2020
Q3
Sell
-79
Closed -$5K 2245
2020
Q2
$5K Sell
79
-851
-92% -$53.9K ﹤0.01% 1664
2020
Q1
$42K Buy
930
+914
+5,713% +$41.3K 0.01% 953
2019
Q4
$0 Sell
16
-18
-53% ﹤0.01% 2456
2019
Q3
$1K Sell
34
-468
-93% -$13.8K ﹤0.01% 2199
2019
Q2
$34K Buy
502
+468
+1,376% +$31.7K 0.01% 1379
2019
Q1
$1K Sell
34
-14
-29% -$412 ﹤0.01% 2167
2018
Q4
$3K Sell
48
-21
-30% -$1.31K ﹤0.01% 1796
2018
Q3
$10K Hold
69
﹤0.01% 1292
2018
Q2
$7K Buy
69
+21
+44% +$2.13K ﹤0.01% 1432
2018
Q1
$4K Hold
48
﹤0.01% 1609
2017
Q4
$3K Hold
48
﹤0.01% 1660
2017
Q3
$3K Buy
48
+22
+85% +$1.38K ﹤0.01% 1660
2017
Q2
$0 Hold
26
﹤0.01% 1961
2017
Q1
$1K Hold
26
﹤0.01% 1822
2016
Q4
$1K Sell
26
-109
-81% -$4.19K ﹤0.01% 1727
2016
Q3
$7K Hold
135
﹤0.01% 1162
2016
Q2
$9K Hold
135
0.01% 1047
2016
Q1
$8K Buy
+135
New +$8K 0.01% 1038